Abstract:Aim: Diabetic neuropathic pain (DNP) is one of the important clinical manifestations of diabetic peripheral neuropathy (DPN). The exact pathogenesis is still unclear. Previous studies suggest that vitamin D family deficiency and complement elevation may be involved in the occurrence and development of DPN. The aim of this study was to further evaluate the possible effects of vitamin D and complement levels on painful DPN. Methods: 120 patients were divided into Non-DPN type 2 diabetic group (n = 37), DPN painless group (n = 43) and DPN pain group (n = 40). Basic data, electromyography results, and laboratory test results (serum 25-hydroxyvitamin D3, erythrocyte sedimentation rate (ESR), complement C3, complement C4, complement C1q, interleukin 6, interleukin 8, glycosylated hemoglobin, etc.) were collected, The patients with DNP were evaluated by DN4 score and VAS score. Results Compared with the control group, the levels of 25-hydroxyvitamin D3 in painful DPN were significantly decreased, and the levels of HBA1c, C3, C4 and C1q were significantly increased (P < 0.05). Vitamin D3 was negatively correlated with the levels of complement C1q 、complement C3 and DN4、VAS score. It was positively correlated with sural and superficial sensory nerve conduction velocity (P < 0.05). Multivariate logistic analysis showed that the decrease of 25-hydroxyvitamin D3 and the increase of complement C3 and C4 were independent risk factors for painful DPN (OR=0.608, 15.378, 2036.988, P < 0.05). Conclusion: The decrease of vitamin D3 and the increase of complement C3 and complement C4 are independent risk factors for painful diabetic peripheral neuropathy in patients with type 2 diabetes. In clinical treatment, the neuropathic pain induced by diabetic peripheral neuropathy can be alleviated by supplementing vitamin D3 and inhibiting complement activation.